GM
Geoff Meacham Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
70
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
64.9%
Neutral
32.5%
Negative
2.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Upgraded
| $14 |
54%
upside
| 1 | +105% |
0
%
| 27 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $54 |
18%
downside
| 1 | +49% |
0
%
| 25 Jun ‘25 8 months ago |
|
|
|
Sell
Initiated
| $6 |
40%
downside
| 1 | -42% |
0
%
| 17 Jun ‘25 8 months ago |
|
|
|
Buy
Maintained
| $140 |
37%
upside
| 2 | +0.81% |
0
%
| 6 May ‘25 10 months ago |
|
|
|
Underperform
Downgraded
| $1 |
67%
downside
| 1 | -228% |
0
%
| 2 Apr ‘25 11 months ago |
|
|
|
Buy
Initiated
| $95 |
34%
upside
| 1 | +84% |
0
%
| 13 Mar ‘25 11 months ago |
|
|
|
Buy
Initiated
| $25 | – | 1 | +78% |
0
%
| 13 Mar ‘25 11 months ago |
|